October 14, 2014 article Open access Tankyrases: Structure, Function and Therapeutic Implications in Cancer Current Pharmaceutical Design DOI: 10.2174/1381612820666140630101525 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 192 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis models 2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 0 citations [1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 2023 Journal of Medicinal Chemistry article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent 30 citations [1,2,4]Triazolo[3,4- b ]benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes 2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine PARP inhibition in cancer therapy Open access 0 citations Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 2022 European Journal of Medicinal Chemistry article Medicine PARP inhibition in cancer therapy Open access 11 citations 4 results References 0